Sort
130,381 grants matching “hiv”
Project 1 - Development of mRNA Immunogens for Protective Antibody Induction
$942,168Barton F Haynes · Duke University · U19 · FY2020 · AI
The Effectiveness of Automated Multimodal Imaging in High Grade Squamous Intraepithelial Lesions (HSIL) Diagnosis for People Living with HIV: An International Trial
$942,063Sharmila Anandasabapathy · Baylor College Of Medicine · R01 · FY2025 · CA
Critical Path IND-enabling Studies, Regulatory, and Product Development
$942,042Robert Walter Buckheit · Imquest Biosciences · U19 · FY2012 · AI
Reducing Latent Viral Reservoirs in Infant Macaques
$941,882Nancy Logan Haigwood · Oregon Health & Science University · R01 · FY2014 · HD
Single-Cell Transcriptomics of Non-Activated Latently Infected T cells Isolated from HIV+ Drug Users
$941,806Melanie Maria Ott · J. David Gladstone Institutes · R33 · FY2023 · DA
Multimodal Imaging of NeuroHIV Dynamics (MIND): An Omaha-Pittsburgh Consortium
$941,747Tony W. Wilson · University Of Nebraska Medical Center · R01 · FY2020 · MH
UAB AIDS/HIV INTERNATIONAL TRAINING &RESEARCH PROGRAM
$941,734University Of Alabama At Birmingham · D43 · FY2002 · TW
Preclinical evaluation of HIV rectal microbicides
$941,685University Of California Los Angeles · U19 · FY2004 · AI
Pathogenic determinants of the SIV envelope transmembrane cytoplasmic domain
$941,644James A Hoxie · University Of Pennsylvania · R01 · FY2009 · AI
Administrative Core
$941,592John T. West · Lsu Health Sciences Center · P20 · FY2025 · GM
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies
$941,513Robert Yarchoan · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
PEDIATRIC AIDS CLINICAL TRIALS GROUP
$941,493Columbia University Health Sciences · U01 · FY2000 · AI
Evaluation of the Immunogenicity and Efficacy of a MVA-HIV Prime, gp145 HIV protein/ALFA-adjuvanted Boost Vaccine Regimen with SHIV-CH505 Challenge in Male Rhesus Macaques
$941,082Ranajit Pal · Advanced Bioscience Laboratories, Inc. · N01 · FY2018 · AI
Optimizing eCD4-Ig for eradication and a functional cure
$941,073Michael R. Farzan · Scripps Florida · R01 · FY2018 · AI
Optimizing eCD4-Ig for eradication and a functional cure
$941,035Michael R. Farzan · Scripps Florida · R01 · FY2020 · AI
The hCNS-HIV/ARV assay system, a platform utilizing human iPSC-neurons/-microglia/-astrocytes to test HIV/AIDS therapeutics for neurotoxicity related to HIV-associated cognitive disroder (HAND)
$940,992Patrick M McDonough · Vala Sciences, Inc. · R44 · FY2022 · MH
Delaware Valley Node of the Clinical Trials Network
$940,977George E Woody · University Of Pennsylvania · U10 · FY2014 · DA
Ohio Valley Node-Network (OVNN) of the NIDA Clinical Trials Network
$940,908T John Winhusen · University Of Cincinnati · UG1 · FY2018 · DA
New Pharmacologic Measures of ART Adherence and Exposure: Pathway to Clinical Implementation
$940,803Jose Ramon Castillo-Mancilla · University Of Colorado Denver · R01 · FY2021 · AI
Pre-clinical progressive selection of a tenofovir analog enema
$940,730Justin S. Hanes · Johns Hopkins University · U19 · FY2016 · AI
A new model of accelerated immune aging in HIV-infected drug users
$940,675Melanie Maria Ott · J. David Gladstone Institutes · DP1 · FY2015 · DA
HIV without AIDS: A Radically Different Approach to Help the Developing World
$940,675Warner C Greene · J. David Gladstone Institutes · DP1 · FY2015 · DA
Structural characterization of MPER-TM immunogens
$940,588Ellis L Reinherz · Dana-Farber Cancer Inst · P01 · FY2024 · AI
MAPs for Peds: Development of a Microarray Patch for Delivery of Long-Acting Antiretrovirals for Treatment of Pediatric HIV Infection
$940,558Robert Kwai Ming Choy · Path · R33 · FY2022 · AI
IMMUNE CONTROL OF HIV REPLICATION
$940,551Massachusetts General Hospital · R01 · FY2002 · AI